Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 32, Issue 1, Pages 3-10
Publisher
Wiley
Online
2016-11-19
DOI
10.1002/jbmr.3039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- (2016) Robert A Adler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Best Practices for Dual-Energy X-ray Absorptiometry Measurement and Reporting: International Society for Clinical Densitometry Guidance
- (2016) E. Michael Lewiecki et al. JOURNAL OF CLINICAL DENSITOMETRY
- Cancel the denosumab holiday
- (2016) M. R. McClung OSTEOPOROSIS INTERNATIONAL
- Executive Summary of the 2015 ISCD Position Development Conference on Advanced Measures From DXA and QCT: Fracture Prediction Beyond BMD
- (2015) John A. Shepherd et al. JOURNAL OF CLINICAL DENSITOMETRY
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years
- (2015) S. Ferrari et al. OSTEOPOROSIS INTERNATIONAL
- Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures
- (2014) Carolyn J. Crandall et al. ANNALS OF INTERNAL MEDICINE
- Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?
- (2014) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Patient Perceptions of Osteoporosis Treatment Thresholds
- (2014) J. M. Neuner et al. JOURNAL OF RHEUMATOLOGY
- Clinician’s Guide to Prevention and Treatment of Osteoporosis
- (2014) F. Cosman et al. OSTEOPOROSIS INTERNATIONAL
- Goal-directed treatment of osteoporosis in Europe
- (2014) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
- (2014) E. S. Siris et al. OSTEOPOROSIS INTERNATIONAL
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis
- (2013) Nelson Watts et al. Endocrine Practice
- Goal-directed treatment of osteoporosis
- (2013) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)
- (2013) Adolfo Díez-Pérez et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Can Change in FRAX Score Be Used to “Treat to Target”? A Population-Based Cohort Study
- (2013) William D Leslie et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treat-to-target for Osteoporosis: Is Now the Time?
- (2013) E. Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy
- (2013) Chris Recknor et al. OBSTETRICS AND GYNECOLOGY
- The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis
- (2013) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspective
- (2012) Steven Boonen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Does osteoporosis therapy invalidate FRAX for fracture prediction?
- (2012) William D Leslie et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene
- (2012) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis
- (2012) Mohammad Hassan Murad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Continuing Bisphosphonate Treatment for Osteoporosis — For Whom and for How Long?
- (2012) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment failure in osteoporosis
- (2012) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
- (2011) Matthew Austin et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial
- (2010) Ann V Schwartz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Time since prior fracture is a risk modifier for 10-year osteoporotic fractures
- (2010) Lora M Giangregorio et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Timing of Subsequent Fractures after an Initial Fracture
- (2010) Tineke A. C. M. van Geel et al. Current Osteoporosis Reports
- Proximal Humeral Fracture as a Risk Factor for Subsequent Hip Fractures
- (2009) Jeremiah Clinton et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Hip Fracture Patients at Risk of Second Hip Fracture: A Nationwide Population-Based Cohort Study of 169,145 Cases During 1977–2001
- (2009) Jesper Ryg et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent
- (2009) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*
- (2008) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Differences in Site-Specific Fracture Risk Among Older Women with Discordant Results for Osteoporosis at Hip and Spine: Study of Osteoporotic Fractures
- (2008) Howard A. Fink et al. JOURNAL OF CLINICAL DENSITOMETRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now